Effects of dopamine and dopamine-derived tetrahydroisoquinolines on Ca++-Mg++-ATPase.
D000818:Animals; D001921:Brain / Q000201:enzymology*; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases / Q000378:metabolism*; D004298:Dopamine / Q000494:pharmacology*; D006220:Haloperidol / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012490:Salsoline Alkaloids / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013570:Synaptic Membranes / Q000201:enzymology*; D044005:Tetrahydroisoquinolines
D007546:Isoquinolines; D012490:Salsoline Alkaloids; D044005:Tetrahydroisoquinolines; C014843:1,2,3,4-tetrahydroisoquinoline; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D006220:Haloperidol; D004298:Dopamine